APO-METFORMIN 500 metformin hydrochloride 500 mg tablet bottle

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

metformin hydrochloride, Quantity: 500 mg

Commercializzato da:

Arrotex Pharmaceuticals Pty Ltd

INN (Nome Internazionale):

Metformin hydrochloride

Forma farmaceutica:

Tablet

Composizione:

Excipient Ingredients: hypromellose; magnesium stearate; colloidal anhydrous silica; macrogol 8000; titanium dioxide; microcrystalline cellulose; hyprolose; methylcellulose

Via di somministrazione:

Oral

Confezione:

500, 100

Tipo di ricetta:

(S4) Prescription Only Medicine

Indicazioni terapeutiche:

Metformin is indicated in the treatment of type 2 diabetes mellitus in adults, children from 10 years of age and adolescents, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control.. For adult patients, metformin may be used as initial treatment or in sulfonylurea failures either alone or in combination with a sulfonylurea and other oral agents or as adjuvant therapy in insulin requiring type 2 diabetes.

Dettagli prodotto:

Visual Identification: White to off-white, round, biconvex, film-coated tablet, scored and engraved "M" over European bisect "500" on one side. Plain on the other side.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Stato dell'autorizzazione:

Licence status A

Data dell'autorizzazione:

2010-04-07